thymine has been researched along with HIV Coinfection in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W | 1 |
| Zhan, P | 1 |
| Wu, J | 1 |
| Li, Z | 1 |
| Liu, X | 1 |
| Ahlenstiel, G | 1 |
| Nischalke, HD | 1 |
| Bueren, K | 1 |
| Berg, T | 1 |
| Vogel, M | 1 |
| Biermer, M | 1 |
| Grünhage, F | 1 |
| Sauerbruch, T | 1 |
| Rockstroh, J | 1 |
| Spengler, U | 1 |
| Nattermann, J | 1 |
| Tanaka, H | 1 |
| Takashima, H | 1 |
| Ubasawa, M | 1 |
| Sekiya, K | 1 |
| Inouye, N | 1 |
| Baba, M | 1 |
| Shigeta, S | 1 |
| Walker, RT | 1 |
| De Clercq, E | 1 |
| Miyasaka, T | 1 |
1 review available for thymine and HIV Coinfection
| Article | Year |
|---|---|
The development of HEPT-type HIV non-nucleoside reverse transcriptase inhibitors and its implications for DABO family.
Topics: Anti-HIV Agents; Crystallography, X-Ray; Drug Design; HIV Infections; HIV Reverse Transcriptase; HIV | 2012 |
1 trial available for thymine and HIV Coinfection
| Article | Year |
|---|---|
The GNB3 C825T polymorphism affects response to HCV therapy with pegylated interferon in HCV/HIV co-infected but not in HCV mono-infected patients.
Topics: Adult; Aged; Antiviral Agents; Cytosine; Drug Therapy, Combination; Female; Genotype; GTP-Binding Pr | 2007 |
1 other study available for thymine and HIV Coinfection
| Article | Year |
|---|---|
Synthesis and antiviral activity of 6-benzyl analogs of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) as potent and selective anti-HIV-1 agents.
Topics: Animals; Antiviral Agents; Benzyl Compounds; HIV Infections; HIV-1; Humans; Lymphocytes; Mice; Micro | 1995 |